PH17073A - Prostaglandin composition - Google Patents

Prostaglandin composition

Info

Publication number: PH17073A
Authority: PH; Philippines
Prior art keywords: prostaglandin; compositions; prostaglandin composition; dissolved; combinations
Prior art date: 1980-10-09

Application number

PH26191A

Other languages

English (en)

Inventor

Gallo-Torres Hugo Enrique

Navnit H Shah

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-10-09

Filing date

1981-09-11

Publication date

1984-05-24

1981-09-11 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

1984-05-24 Publication of PH17073A publication Critical patent/PH17073A/en

Links

150000003180 prostaglandins Chemical class 0.000 title abstract 3
239000000203 mixture Substances 0.000 title abstract 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
239000011786 L-ascorbyl-6-palmitate Substances 0.000 abstract 2
235000000072 L-ascorbyl-6-palmitate Nutrition 0.000 abstract 1
QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 abstract 1
239000002202 Polyethylene glycol Substances 0.000 abstract 1
229960005070 ascorbic acid Drugs 0.000 abstract 1
235000010385 ascorbyl palmitate Nutrition 0.000 abstract 1
235000014113 dietary fatty acids Nutrition 0.000 abstract 1
239000002552 dosage form Substances 0.000 abstract 1
229930195729 fatty acid Natural products 0.000 abstract 1
239000000194 fatty acid Substances 0.000 abstract 1
150000004665 fatty acids Chemical class 0.000 abstract 1
239000007903 gelatin capsule Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
229920001223 polyethylene glycol Polymers 0.000 abstract 1
229920000136 polysorbate Polymers 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PH26191A 1980-10-09 1981-09-11 Prostaglandin composition PH17073A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US06/195,575 US4310543A (en)	1980-10-09	1980-10-09	Prostaglandin compositions

Publications (1)

Publication Number	Publication Date
PH17073A true PH17073A (en)	1984-05-24

Family

ID=22721933

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PH26191A PH17073A (en)	1980-10-09	1981-09-11	Prostaglandin composition

Country Status (13)

Country	Link
US (1)	US4310543A (fr)
EP (1)	EP0049852B1 (fr)
JP (1)	JPS5793911A (fr)
AT (1)	ATE14981T1 (fr)
AU (1)	AU547175B2 (fr)
CA (1)	CA1176567A (fr)
DE (1)	DE3171928D1 (fr)
DK (1)	DK442881A (fr)
IE (1)	IE51637B1 (fr)
IL (1)	IL63960A (fr)
NZ (1)	NZ198533A (fr)
PH (1)	PH17073A (fr)
ZA (1)	ZA816852B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ204924A (en) *	1982-07-19	1986-09-10	Syntex Inc	Pge-type prostaglandins in stabilising solvent encapsulated in type a gelatin
US4431833A (en) *	1982-12-27	1984-02-14	American Cyanamid Company	Prostaglandin and hydroxylated fatty acid ester formulations
FR2549371B1 (fr) *	1983-07-20	1985-09-13	Sanofi Sa	Nouvelle composition pharmaceutique contenant de l'acide valproique ou un de ses sels
NL8520012A (nl) *	1984-02-08	1986-01-02	Scherer Corp R P	Aceetaminofeen gelatinecapsule, die snelle aanvang van therapeutische activiteit na orale toediening oplevert.
DE3438830A1 (de) *	1984-10-23	1986-04-30	Rentschler Arzneimittel	Nifedipin enthaltende darreichungsform und verfahren zu ihrer herstellung
NO882653D0 (no) *	1988-06-15	1988-06-15	Apothekernes Lab	Doseringsform.
EP0458588B1 (fr) *	1990-05-22	1994-11-30	R-Tech Ueno Ltd.	Traitement de l'hypertension oculaire à l'aide d'une combinaison synergique pour l'application ophtalmique
GB2281697A (en) *	1993-09-14	1995-03-15	Euro Celtique Sa	Laxative compositions in capsules
US6180666B1 (en)	1997-09-05	2001-01-30	Anmax, Inc.	Use of gallic acid esters to increase bioavailability of orally administered pharmaceutical compounds
US5962522A (en) *	1997-09-05	1999-10-05	Avmax, Inc.	Propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
AU6107500A (en) *	1999-07-13	2001-01-30	Avmax, Inc.	Improvement of bioavailability with vitamin c fatty acid esters
KR100649860B1 (ko) *	2000-09-01	2006-11-24	주식회사종근당	알프로스타딜 경점막 및 경피흡수제제
PT1321144E (pt) *	2000-09-13	2011-03-10	Santen Pharmaceutical Co Ltd	Colírio
US20060199863A1 (en) *	2003-07-31	2006-09-07	Santen Pharmaceutical Co., Ltd.	Product containing prostaglandin
KR101152470B1 (ko)	2003-08-13	2012-06-01	바이오콘 리미티드	치료제용 마이크로-입자 지방산 염 고형 투약 제형
US20050123602A1 (en) *	2003-09-25	2005-06-09	Michaelis Arthur F.	Rifalazil formulations
US9993558B2 (en)	2004-10-01	2018-06-12	Ramscor, Inc.	Sustained release eye drop formulations
US8541413B2 (en) *	2004-10-01	2013-09-24	Ramscor, Inc.	Sustained release eye drop formulations
CA2590277C (fr) *	2004-12-09	2014-07-08	Santen Pharmaceutical Co., Ltd.	Produit contenant de la prostaglandine dont la molecule comporte un atome de fluor
DK1829545T3 (da) *	2004-12-24	2012-07-23	Santen Pharmaceutical Co Ltd	Produkter indeholdende prostaglandin-F2alfa-derivat
MX2008012844A (es) *	2006-04-06	2009-01-19	Activbiotics Pharma Llc	Composiciones farmaceuticas y usos de ellas.
CN101808623B (zh) *	2007-07-19	2013-08-14	株式会社·R-技术上野	包含11-脱氧-前列腺素化合物的药物组合物和使该化合物稳定化的方法
WO2009052391A1 (fr) *	2007-10-19	2009-04-23	Purdue Research Foundation	Formulations solides de composés cristallins

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2889252A (en) *	1956-05-14	1959-06-02	American Cyanamid Co	Gelatin capsule containing hexylresorcinol and a lower polyalkylene glycol
ZA721937B (en) *	1971-10-22	1972-12-27	Upjohn Co	Pharmaceutical preparations and uses thereof
CA1043259A (fr) *	1972-12-08	1978-11-28	Geoffrey F. Thompson	Preparation medicinale et excipient approprie
US3932634A (en) *	1973-06-28	1976-01-13	Pfizer Inc.	High potency vitamin water dispersible formulations
US4052446A (en) *	1973-08-06	1977-10-04	Hoffmann-La Roche Inc.	11,16-substituted prostaglandins
JPS6019734B2 (ja) *	1977-05-12	1985-05-17	三共株式会社	安定なプロスタグランジンｅ類製剤の製法
JPS6046094B2 (ja) *	1977-06-01	1985-10-14	科研製薬株式会社	安定化されたプロスタグランジンｅ類粉末製剤
DE2900428A1 (de) *	1978-01-17	1979-07-19	Sandoz Ag	Prostaglandine enthaltende therapeutische zusammensetzung

1980
- 1980-10-09 US US06/195,575 patent/US4310543A/en not_active Expired - Lifetime
1981
- 1981-09-09 CA CA000385446A patent/CA1176567A/fr not_active Expired
- 1981-09-11 PH PH26191A patent/PH17073A/en unknown
- 1981-09-28 IL IL63960A patent/IL63960A/xx unknown
- 1981-10-02 ZA ZA816852A patent/ZA816852B/xx unknown
- 1981-10-02 NZ NZ198533A patent/NZ198533A/en unknown
- 1981-10-06 DE DE8181107988T patent/DE3171928D1/de not_active Expired
- 1981-10-06 EP EP81107988A patent/EP0049852B1/fr not_active Expired
- 1981-10-06 DK DK442881A patent/DK442881A/da not_active Application Discontinuation
- 1981-10-06 AU AU76068/81A patent/AU547175B2/en not_active Ceased
- 1981-10-06 AT AT81107988T patent/ATE14981T1/de active
- 1981-10-08 IE IE2354/81A patent/IE51637B1/en unknown
- 1981-10-08 JP JP56159562A patent/JPS5793911A/ja active Granted

Also Published As

Publication number	Publication date
DE3171928D1 (en)	1985-09-26
JPH032848B2 (fr)	1991-01-17
EP0049852B1 (fr)	1985-08-21
AU547175B2 (en)	1985-10-10
IL63960A (en)	1985-05-31
JPS5793911A (en)	1982-06-11
IE812354L (en)	1982-04-09
DK442881A (da)	1982-04-10
EP0049852A2 (fr)	1982-04-21
CA1176567A (fr)	1984-10-23
ZA816852B (en)	1982-09-29
IE51637B1 (en)	1987-01-21
NZ198533A (en)	1984-12-14
ATE14981T1 (de)	1985-09-15
EP0049852A3 (en)	1983-01-26
IL63960A0 (en)	1981-12-31
US4310543A (en)	1982-01-12
AU7606881A (en)	1982-04-22

Similar Documents

Publication	Publication Date	Title
AU547175B2 (en)	1985-10-10	Stabilised prostaglandin formulations
DE3172223D1 (en)	1985-10-17	Edible, pharmaceutical compositions and processes for making thereof
IL69081A0 (en)	1983-10-31	Benzoic acid piperidyl ester derivatives,their preparation and pharmaceutical compositions containing them
ATE172183T1 (de)	1998-10-15	Ester und kombinationen von einem organischen nitrat und einem salicyclat
IL56991A0 (en)	1979-07-25	4-halo-3-oxoandrost-4-ene-17 -thiocarboxylic acid esters their preparation and pharmaceutical compositions containing them
EE03425B1 (et)	2001-06-15	Lihtsa koostise ja kõrge biosaadavusega tsüklosporiini preparaadid suu kaudu manustamiseks ja nende valmistamismeetod
FR2321892A1 (fr)	1977-03-25	Preparations pharmaceutiques pour l'administration orale renfermant un ester-17b de nandrolone et nouveaux esters-17b de nandrolone
IE893718L (en)	1990-05-22	Pharmaceutical Compositions
GB8812653D0 (en)	1988-06-29	Pharmaceutical composition based on high concentration esters of docosahexaenoic acid
FR2490491B1 (fr)	1986-10-10	Composition pharmaceutique analgesique contenant comme ingredient actif l'acide 3-amino-2-hydroxy-4 phenylbutanoique et ses derives et application
DE3164338D1 (en)	1984-07-26	Conjugated polyprenylcarboxylic acids and their derivatives as well as pharmaceutical preparations containing these compounds
PH18056A (en)	1985-03-18	Pharmaceutical formulations of cisplatin
IL56435A0 (en)	1979-03-12	Pharmaceutical compositions containing prostaglandins
JPS5551019A (en)	1980-04-14	Drug containing alllee or 133zz7*88dehydroo retine acid and manufacture thereof
DE2967551D1 (en)	1986-01-16	5(6)-(2-amino-5-thiazoloyl)benzimidazole-2-carbamic acid esters and their salts, their preparation and use, and pharmaceutical compositions containing them
GB1321419A (en)	1973-06-27	Pharmaceutical composition
JPS52130905A (en)	1977-11-02	Medicinal composition
BE881625A (fr)	1980-05-30	Esters o-alcoxycarbonyl-phenyliques d'un acide anthranilique leur preparation et compositions pharmaceutiques en contenant
AU529728B2 (en)	1983-06-16	Esters of arylpropionic acid derivatives, their preparation and pharmaceutical compositions containing them
IL56487A (en)	1983-05-15	Quaternary salts of bis isoquinolinoalkyl benzene dicarboxylic acid esters,their preparation and pharmaceutical compositions containing them
FR2607005B1 (fr)	1989-05-05	Compositions pharmaceutiques contenant de l'acide ursodesoxycholique
JPS5764609A (en)	1982-04-19	Cyclophosphamide composition for rectal administration
IL57859A0 (en)	1979-11-30	Salts of benzene and thiophene-carbothioic acid 2-aminoalkl esters and pharmaceutical compositions containing them
IL58154A0 (en)	1979-12-30	1-methyl-4-piperidinol esters their preparation and pharmaceutical compositions containing them
JPS55361A (en)	1980-01-05	Method of using thienoyl peroxide as drug and toiletary substance and pharmaceutical and toiletary composition containing it